AI roadmap
Potential assistance with organization and drafting will require validation, monitoring, and clinician oversight before use.
Technology & data
From Biosignal to Clinician Review to Completed Care.
MaraTech USA begins by working with the laboratory results and clinical information a practice already has—without requiring new testing equipment.
From signal to evidence
⌁SignalExisting results enter the workflow.→
◉ReviewThe right review window is identified.→
➜ActionA clinician selects the next step.→
✓CompletionFollow-up is tracked to completion.→
▥EvidenceOutcomes support continuous improvement.
Start With Existing Laboratory Results
The initial program uses results a practice already receives. It focuses on the missing operational layer between a biosignal, clinician review, and completion of the practice-selected next step.
DATA PRINCIPLES
- Minimum necessary information
- Source traceability
- Clear data provenance
- Role-based workflow design
- Human review before action
- Measured operational performance
Privacy and security readiness
Before receiving protected health information, MaraTech USA and each participating practice will define roles, permitted uses, access, retention, and required agreements. This public website is not a channel for patient information.
What comes next
NanoWell roadmap
Future sensing capabilities are a separate development track requiring analytical and clinical validation, quality systems, contracts, regulatory assessment, and evidence.
Strategic partnerships
Provider, laboratory, pharmaceutical, and payer collaborations may follow validated workflows and governed data relationships.
Start with your current workflow
Build the workflow before scaling the platform.
We welcome conversations with practices and aligned strategic partners.